GENZYME CORP Net Income (Loss), Including Portion Attributable to Noncontrolling Interest
GENZYME CORP reported Net Income (Loss), Including Portion Attributable to Noncontrolling Interest of $471.91 million for the 3-month period ending 2010-12-31, per its 10-K filed 2011-03-01.
Discontinued › Income Statement › Net Income
us-gaap:ProfitLoss · last filed 2011-03-01
- GENZYME CORP net income (loss), including portion attributable to noncontrolling interest for the quarter ending 2010-12-31 was $471.91M, a 1930.16% increase year-over-year.
- GENZYME CORP net income (loss), including portion attributable to noncontrolling interest for the quarter ending 2010-09-30 was $68.95M, a 331.10% increase year-over-year.
- GENZYME CORP net income (loss), including portion attributable to noncontrolling interest for the quarter ending 2010-06-30 was -$3.77M, a 102.01% decline year-over-year.
- GENZYME CORP net income (loss), including portion attributable to noncontrolling interest for the quarter ending 2010-03-31 was -$114.95M, a 158.80% decline year-over-year.
- GENZYME CORP net income (loss), including portion attributable to noncontrolling interest for fiscal 2010 was $422.14M, a 0.04% decline from fiscal 2009.
- GENZYME CORP net income (loss), including portion attributable to noncontrolling interest for fiscal 2009 was $422.30M, a 0.29% increase from fiscal 2008.
- GENZYME CORP net income (loss), including portion attributable to noncontrolling interest for fiscal 2008 was $421.08M.
| Period end | Net Income (Loss), Including Portion Attributable to Noncontrolling Interest 3 month | Net Income (Loss), Including Portion Attributable to Noncontrolling Interest 6 month | Net Income (Loss), Including Portion Attributable to Noncontrolling Interest 9 month | Net Income (Loss), Including Portion Attributable to Noncontrolling Interest 12 month |
|---|---|---|---|---|
| 2010-12-31 | $471.91M 10-K · filed 2011-03-01 | $540.87M derived: sum of 2 quarters · filed 2011-03-01 | $537.09M derived: sum of 3 quarters · filed 2011-03-01 | $422.14M 10-K · filed 2011-03-01 |
| 2010-09-30 | $68.95M 10-K · filed 2011-03-01 | $65.18M derived: sum of 2 quarters · filed 2011-03-01 | -$49.77M 10-Q · filed 2010-11-09 | -$26.52M derived: sum of 4 quarters · filed 2011-03-01 |
| 2010-06-30 | -$3.77M 10-K · filed 2011-03-01 | -$118.72M 10-Q/A · filed 2010-09-07 | -$95.48M derived: sum of 3 quarters · filed 2011-03-01 | -$79.48M derived: sum of 4 quarters · filed 2011-03-01 |
| 2010-03-31 | -$114.95M 10-K · filed 2011-03-01 | -$91.70M derived: sum of 2 quarters · filed 2011-03-01 | -$75.71M derived: sum of 3 quarters · filed 2011-03-01 | $111.87M derived: sum of 4 quarters · filed 2011-03-01 |
| 2009-12-31 | $23.25M 10-K · filed 2011-03-01 | $39.24M derived: sum of 2 quarters · filed 2011-03-01 | $226.81M derived: sum of 3 quarters · filed 2011-03-01 | $422.30M 10-K · filed 2011-03-01 |
| 2009-09-30 | $15.99M 10-K · filed 2011-03-01 | $203.57M derived: sum of 2 quarters · filed 2011-03-01 | $399.06M 10-Q · filed 2010-11-09 | $485.70M derived: sum of 4 quarters · filed 2011-03-01 |
| 2009-06-30 | $187.57M 10-K · filed 2011-03-01 | $383.06M 10-Q/A · filed 2010-09-07 | $469.71M derived: sum of 3 quarters · filed 2011-03-01 | $589.31M derived: sum of 4 quarters · filed 2011-03-01 |
| 2009-03-31 | $195.49M 10-K · filed 2011-03-01 | $282.14M derived: sum of 2 quarters · filed 2011-03-01 | $401.73M derived: sum of 3 quarters · filed 2011-03-01 | $471.30M derived: sum of 4 quarters · filed 2011-03-01 |
| 2008-12-31 | $86.65M derived: 10-K 12 month − 10-Q 9 month · filed 2011-03-01 | $206.25M derived: sum of 2 quarters · filed 2011-03-01 | $275.81M derived: sum of 3 quarters · filed 2011-03-01 | $421.08M 10-K · filed 2011-03-01 |
| 2008-09-30 | $119.60M 10-Q · filed 2009-11-02 | $189.16M derived: sum of 2 quarters · filed 2009-11-02 | $334.43M 10-Q · filed 2009-11-02 | |
| 2008-06-30 | $69.56M 10-Q/A · filed 2009-09-04 | $214.84M 10-Q/A · filed 2009-09-04 | ||
| 2007-12-31 | $480.19M 8-K · filed 2010-06-14 |